COMPLETED

Mindful Minds: Mindfulness-Based Neurofeedback for Underrepresented College Students

Conditions

Academic Performance Anxiety neurofeedback underrepresented population college students mindfulness meditation wearable devices biofeedback Heart Rate Variability Alpha Neurofeedback

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study examines the efficacy of a mindfulness-based neurofeedback protocol designed to improve academic performance and reduce performance anxiety in racial and ethnic minority college students. Using NeuroSky and BrainTrain technology, the intervention incorporates mindfulness principles to enhance participants' self-regulation skills. Continuous heart rate variability (HRV) data is collected to assess stress levels, sleep, and exercise. The research aims to explore the acceptability and feasibility of this approach, with the goal of addressing academic performance and anxiety in this population.

Official Title

Mindful Minds: Acceptability and Feasibility of Mindfulness-Based Neurofeedback Training for Racial and Ethnic Minority Scholars

Quick Facts

Study Start:2025-01-28

Study Completion:2025-03-25

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:COMPLETED

Study ID

NCT06784934

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 30 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT

Inclusion Criteria	Exclusion Criteria
* Aged between 18 and 30 years old * Currently enrolled in a 4-year university * Individuals from an ethnic or racial minority background (i.e., "The minority racial and ethnic groups defined by Office of Management and Budget's (OMB) are American Indian or Alaska Native, Asian, Black or African American, and Native Hawaiian or Pacific Islander. The ethnicity used is Latino or Hispanic.")	* Severe depression (cut off score of 15 or higher on Patient Health Questionnaire 9 (PHQ-9)) * Previously receiving biofeedback training. * Severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes). * Showing symptoms of psychosis * Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data. * Taking medications such as SSRIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone) * Using substances such as tobacco and illicit drugs, and 8)alcohol consumption as defined by National Institute of Health (NIH) as "more than 2 drinks (1 drink for women) in a day or drinking more than 5 drinks (4 for women) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past month" are excluded due to their potential to affect the data.

Inclusion Criteria

Exclusion Criteria

* Aged between 18 and 30 years old
* Currently enrolled in a 4-year university
* Individuals from an ethnic or racial minority background (i.e., "The minority racial and ethnic groups defined by Office of Management and Budget's (OMB) are American Indian or Alaska Native, Asian, Black or African American, and Native Hawaiian or Pacific Islander. The ethnicity used is Latino or Hispanic.")

* Severe depression (cut off score of 15 or higher on Patient Health Questionnaire 9 (PHQ-9))
* Previously receiving biofeedback training.
* Severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes).
* Showing symptoms of psychosis
* Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data.
* Taking medications such as SSRIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone)
* Using substances such as tobacco and illicit drugs, and 8)alcohol consumption as defined by National Institute of Health (NIH) as "more than 2 drinks (1 drink for women) in a day or drinking more than 5 drinks (4 for women) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past month" are excluded due to their potential to affect the data.

Contacts and Locations

Principal Investigator

Amelia D Saul, PhD

PRINCIPAL_INVESTIGATOR

Florida International University

Study Locations (Sites)

Florida International University

Miami, Florida, 33199

United States

Collaborators and Investigators

Sponsor: Florida International University

Amelia D Saul, PhD, PRINCIPAL_INVESTIGATOR, Florida International University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-28

Study Completion Date2025-03-25

Study Record Updates

Study Start Date2025-01-28

Study Completion Date2025-03-25

Terms related to this study

Keywords Provided by Researchers

neurofeedback
underrepresented population
college students
academic performance
anxiety
mindfulness meditation
wearable devices
biofeedback
Heart Rate Variability
Alpha Neurofeedback

Additional Relevant MeSH Terms

Academic Performance
Anxiety